Overview

Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI

Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Significant changes in brain morphology are observed in people with first-episode psychosis. Studies have shown that total brain volume and particular brain structures are decreased in people with psychosis disorders. Recent evidence suggests that some atypical antipsychotic drugs can maintain or increase brain volumes. Thus, we plan to use MRI scans to measure changes in brain morphology in subjects recently diagnosed with bipolar or psychosis disorders who are taking the atypical antipsychotic drugs aripiprazole or risperidone. Secondary objectives include taking blood samples for fasting metabolic indices and neuropsychiatric measures for comparisons between drug treatments.
Details
Lead Sponsor:
University of British Columbia
Collaborator:
Vancouver Coastal Health
Treatments:
Aripiprazole
Risperidone